HY05350

· Sichuan Huiyu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HY05350, covering 2025-11-25 to 2025-11-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study of HY05350 in Mesothelin(MSLN)-Positive Advanced Solid Tumors [Phase 1, Phase 2]